| Date Posted |
Subject |
| Dec. 30, 2004 |
Methods for determining suitability of lipemic samples for disease marker testing ADDENDA Jan. 2, 2005 |
| Dec. 28, 2004 |
Is gamma irradiation (like that used to prevent GVHD) a feasible strategy to limit bacterial growth in platelet components? ADDENDA Dec. 28, 29 & 30 |
| Dec. 26, 2004 |
Experience in using electronic medical records for ordering and documenting blood transfusions |
| Dec. 18, 2004 |
Deferral policies for prospective blood donors who have been "branded" as a result of pledging a fraternity ADDENDA Dec. 21 & 27 |
| Dec. 18, 2004 |
Eligibility of prospective blood donors who have had a conjugal visit within the past 12 months with an individual who is incarcerated in prison ADDENDA Dec. 21 |
| Dec. 17, 2004 |
Use of dielectric heating tube sealers to stop the flow of blood at the completion of donor phlebotomy |
| Dec. 14, 2004 |
Ramifications of selling expired autologous blood ADDENDA Dec. 20 |
| Dec. 14, 2004 |
Blood administration during dialysis ADDENDA Dec. 14 & Feb. 24 & 25, 2005 |
| Dec. 12, 2004 |
Prophylactic Rh phenotype matching for patients demonstrating anti-E or anti-C ADDENDA Dec. 13 |
| Dec. 10, 2004 |
Eligibility of prospective blood donors who have autoimmune disease |
| Dec. 7, 2004 |
Maintaining 'warm temperature' for specimens collected for cold agglutinin testing ADDENDA Dec. 7 |
| Dec. 6, 2004 |
Donor deferral period after receipt of Rh immunoglobulin ADDENDA Dec. 10 |
| Nov. 29, 2004 |
Risk of hyperkalemia from irradiated Red Cells used to prime ECMO circuits in neonates ADDENDA Jan. 11 & 14, 2005; Jan. 22, 2007 |
| Nov. 26, 2004 |
Routine performance of prophylactic phenotype matching ADDENDA Dec. 12, 13 & 16; Feb. 6, 2005 |
| Nov. 26, 2004 |
Must a current blood sample always be tested for Rho(D) type prior to administration of Rh immune globulin? ADDENDA Nov. 30, Dec. 5, 18 & 21 |
| Nov. 23, 2004 |
Integration of transfusion avoidance and conservation programs with Hospital Transfusion Committees ADDENDA Nov. 24 & 26 |
| Nov. 23, 2004 |
Neonatal transfusion practices for prevention of CMV transmission ADDENDA Nov. 27 & 30 |
| Nov. 19, 2004 |
Logistics of manufacturing platelets and FFP on an island country in the South Pacific ADDENDA Nov. 28 |
| Nov. 18, 2004 |
Acceptability of conducting Utilization Review Committee meetings by e-mail ADDENDA Nov. 19 |
| Nov. 17, 2004 |
Risk of transfusing ABO-incompatible plasma to recipients of ABO-compatible bone marrow transplants ADDENDA Nov. 18 & 19 |
| Nov. 16, 2004 |
Management of uncrossmatched blood products issued to the emergency room ADDENDA Nov. 16, 17 & 22; Apr. 13, 2005 |
| Nov. 11, 2004 |
Is there a JCAHO requirement to perform ABO/Rh testing on the post-reaction patient sample and repeat ABO/Rh testing of the implicated RBC unit in transfusion reaction investigations? ADDENDA Nov. 12 & 16 |
| Nov. 9, 2004 |
Switching
from uncrossmatched type O to type-specific Red
Cells in urgent bleeding situations ADDENDA Nov.
9, 23, 29 & Dec.
5; Dec. 12, 2007 |
| Nov. 5, 2004 |
Use of the EDTA-Glycine-Acid Method for Red Cell autoadsorption and phenotyping in patients with autoantibodies ADDENDA Nov. 8 & 22; Jan. 9, 2005 |
| Nov. 4, 2004 |
Clarification of the maximum time allowed for infusion of blood components ADDENDA Nov. 7, 8, 18, 26, 29 & Dec. 12 |
| Nov. 1, 2004 |
Managing Red Cells whose temperature falls below 1 degree C during long shipment on airplanes ADDENDA May 9, 2005 |
| Oct. 30, 2004 |
Informed consent for administration of Rh Immune Globulin |
| Oct. 29, 2004 |
Disposition of Red Cells exposed to freezing temperatures during shipping |
| Oct. 28, 2004 |
Using School Athletic Events to Promote Blood Donation ADDENDA Oct. 29 & Nov. 4 |
| Oct. 28, 2004 |
Written instructions for transfusion recipients about possible adverse reactions ADDENDA Nov. 12 |
| Oct. 19, 2004 |
Donor deferral for recipients of nasal spray flu vaccine ADDENDA Oct. 20 |
| Oct 18, 2004 |
Selection of compatible red cells for a patient with anti-M ADDENDA Oct. 19 & 29 |
| Oct. 11, 2004 |
Use and QC of 'platelet gel' ADDENDA Jan. 20, 2005; Feb. 1, 2005 |
| Oct. 7, 2004 |
Managing routine requests for autologous donation by surgeons for the main purpose of obtaining the result of a patient's HIV test before surgery |
| Oct. 6, 2004 |
Can expired panel cells be used in a manner that would be considered compliant? ADDENDA Oct. 7; Aug. 19, 28 & 30, 2005 |
| Oct. 5, 2004 |
Post-irradiation storage of Red Cells intended for transfusion to neonates ADDENDA Oct. 7 & 19 |
| Sept. 24, 2004 |
Compatibility Testing for Autologous Red Cell Units ADDENDA Sept. 28 & 30, Oct. 3, 5, 20 & 31; Feb. 16, 2006 |
| Sept. 23, 2004 |
Acceptability of lipemic apheresis platelets for transfusion |
| Sept. 22, 2004 |
Policies on verification of typing of antigen-negative red cell units received from blood suppliers ADDENDA Sept. 23, 28, 29 & 30, Oct. 3 |
| Sept. 21, 2004 |
TRALI after IV anti-D (RhIg) ADDENDA Sept. 29 |
| Sept. 19, 2004 |
Irradiation of cellular blood products intended for patients with HIV/AIDS |
| Sept. 15, 2004 |
Donor eligibility for persons with systemic lupus erythematosus |
| Sept. 12, 2004 |
If the blood bank labeling policy requires use of a separate blood bank wristband, is it acceptable in certain instances to use a sample from another area of the laboratory? ADDENDA Sept. 14 |
| Sept. 9, 2004 |
What quality assurance indicators are best to use for perioperative blood salvage? ADDENDA Sept. 19 & 30, Oct. 6; Jan. 13, 2009 |
| Sept. 7, 2004 |
Deferral policies on donors unable to definitively ascertain the source of prior insulin injections ADDENDA Sept. 8 |
| Sept. 6, 2004 |
Management of a pregnant woman who may have native anti-D, but has also received an antepartum dose of RhIG |
| Sept. 6, 2004 |
Simultaneous infusion of deferoxamine (Desferal) and red cells ADDENDA Sept. 8, 9 & 14; Aug. 17, 2005; Apr. 4 & 28, 2006 |
| Sept 3, 2004 |
Management of patients with anti-Cw in the absence of commercial anti-Cw typing reagent ADDENDA Sept. 7, 8 & 10 |
| Sept 1, 2004 |
Survey on current practices in prevention of transfusion transmitted sepsis syndrome |
| Aug. 31, 2004 |
Testing newborns for their ABO group status ADDENDA Sept. 2 |
| Aug. 27, 2004 |
Risk of post-transfusion thrombocytopenia after red cell transfusions in patients with anti-PlA1 (HPA1) ADDENDA Aug. 31, Sept. 6, 7 & 8 |
| Aug. 25, 2004 |
Management of donors with a single reactive test for anti-HBc ADDENDA May 23, 2008 |
| Aug. 25, 2004 |
Rinsing bags of cryoprecipitate with saline before pooling ADDENDA Aug. 26, 27, 31, Sept. 6 & 7 |
| Aug. 22, 2004 |
Policies on combining ABO non-identical platelet concentrates in the same pool ADDENDA Aug. 23 & 27 |
| Aug. 21, 2004 |
Antibody stability in plasma/serum samples stored in direct contact with red cells ADDENDA Aug. 23, 24 & 25 |
| Aug. 20, 2004 |
Management of multiple blood product label barcoding systems between suppliers and hospitals ADDENDA Aug. 25; Sept. 29, 2008 |
| Aug. 17, 2004 |
Implementing a home transfusion program |
| Aug. 15, 2004 |
An alternative approach to ABO/Rh donor unit confirmation testing ADDENDA Aug. 21 |
| Aug. 11, 2004 |
Whole blood for cardiac bypass surgery - how fresh should it be? ADDENDA Aug. 16 & 17 |
| Aug. 10, 2004 |
Should the attending physician be allowed to determine the initiation of a transfusion reaction investigation? ADDENDA Aug. 17 & 25 |
| Aug. 10, 2004 |
Indications for and use of the 'Biological Crossmatch' ADDENDA Aug. 11, 12, 16 & 17, Sept. 22; Nov. 2, 2006 |
| Aug. 9, 2004 |
Methods for documenting blood component irradiation ADDENDA Aug. 10, 13, 17 & 29 |
| Aug. 4, 2004 |
Maintaining control of lot release function when transferred to a centralized department within collections |
| Aug. 2, 2004 |
Use of IV Immune Globulin (IVIg) to reduce the need for exchange transfusion in hemolytic disease of the newborn |
| July 30, 2004 |
Invalid test runs when using external controls for NAT testing to screen donors for HIV and HCV; ADDENDA Apr. 21, 2005 |
| July 28, 2004 |
Use of Red Cells from which a small aliquot has been removed for a pediatric patient ADDENDA July 29, Aug. 3 & 6 |
| July 26, 2004 |
Safety and validation issues in considering a switch from glass to plastic tubes for testing donors and patients ADDENDA Jan 31 & Feb 2, 2005 |
| July 22, 2004 |
Outsourcing look-back investigations for recalled blood products ADDENDA July 26 |
| July 21, 2004 |
Use of Rh immune globulin (RhIg) in Rh-negative female children receiving platelets from Rh-positive donors ADDENDA July 26 |
| July 21, 2004 |
Automatic protocols for dealing with massive transfusion ADDENDA July 23 & 26, Aug. 2, 4, 5, 6, 11 & 18, Sept 22, Oct 31, Nov 9, Dec 5 & 18; June 26, July 3 & 16, 2008; Jan. 18 & 28, 2009 |
| July 18, 2004 |
The acceptability of storing an allogeneic unit on the autologous blood shelf ADDENDA July 20 |
| July 12, 2004 |
A case of unexplained hemoglobinuria after transfusion of frozen-deglycerolized autologous red cells ADDENDA July 14 & 15 |
| July 11, 2004 |
Handling a recall of prior collections from a donor who admits to a past diagnosis of multiple sclerosis |
| July 10, 2004 |
Protocols for apheresis in treating heart/kidney transplant rejection ADDENDA July 13 & Aug. 2 |
| July 7, 2004 |
Blood bank identification bands for neonates ADDENDA Dec 15, 2004 |
| July 1, 2004 |
Questions about the new Uniform Donor History Questionnaire |
| June 28, 2004 |
Practical concerns regarding the location of a hospital blood bank away from the operating rooms ADDENDA June 29 & July 8; Feb. 26, 2007 |
| June 22, 2004 |
An apparent hemolytic transfusion reaction of unresolved etiology |
| June 21, 2004 |
Role of the husband's Rh (D) status in policies for administering RhIg to pregnant Rh-negative women ADDENDA June 30, Aug. 18, Sept 17 & 29 |
| June 19, 2004 |
Re-entry of donors who tested positive in an HCV ELISA antibody screen but RIBA-negative, prior to implementation of HCV-RNA testing ADDENDA June 22; Jan. 28, 2009 |
| June 19, 2004 |
Revisions for the package inserts for the 0.8% Reagent Red Blood Cell product line which is used with the GEL Technology ADDENDA Jan. 16 & 18, 2006 |
| June 17, 2004 |
Does a history of transient passively acquired anti-D from receipt of RhIG disqualify a patient for an electronic crossmatch? ADDENDA June 23 |
| June 14, 2004 |
Criteria for performing repeat antibody identification panel workups ADDENDA June 16 & 22, Sept 15 & 21 |
| June 10, 2004 |
Methods for ensuring correct identification of patients who have pre-transfusion blood samples drawn before admission for surgery ADDENDA June 11, 13, 17 & 25, July 15, Aug. 5, Oct 4 |
| June 10, 2004 |
Methods of preparing a unit of whole blood for centrifugation ADDENDA June 11 & 12 |
| June 7, 2004 |
Maximum collection time for whole blood intended for manufacture of labile components (platelets, FFP, cryoprecipitate) ADDENDA June 8 & 10; Aug. 27, 2008 |
| June 3, 2004 |
Policies about donor center staff changing gloves between donors ADDENDA June 4, 6 & 7 |
| May 30, 2004 |
Policies on the management of hearsay information received about otherwise qualified blood donors ADDENDA June 3 & 4; Aug. 3, 2006 |
| May 25, 2004 |
Assessing the competence of physicians to transfuse blood products safely ADDENDA May 25 & 26 |
| May 25, 2004 |
Minimizing wastage of Red Cells stored in the operating room for liver transpants ADDENDA May 26 & 27, June 1 |
| May 18, 2004 |
Eligibility of prospective blood donors known to have G6PD deficiency ADDENDA May 18, 24 & 27 |
| May 17, 2004 |
Guidelines on the acceptance criteria of annual testing performed on plasmapheresis donors |
| May 15, 2004 |
Which hospital department(s) should manage the storage, dispensing, reconstitution and administration of clotting factor concentrates? ADDENDA May 17 & 19 |
| May 12, 2004 |
Monitoring vital signs during and after blood transfusion - revisited ADDENDA May 13, 2004; Mar. 27 & June 11, 2007 |
| May 11, 2004 |
What are the personnel requirements for pre-transfusion verification of intended recipient, documents and component? -revisited; ADDENDA May 12 |
| May 6, 2004 |
The use of leukocyte-reduced components for liver transplant candidates/recipients ADDENDA May 11 |
| May 5, 2004 |
Policies on the use of autologous units that test positive for HIV, HBV and/or HCV ADDENDA May 6, 2004 ; Aug. 3, 6, 8 & 9, 2005; Mar. 22, 209 |
| May 4, 2004 |
Consideration of the implementation of the Procleix Ultrio Hepatitis B assay ADDENDA May 6 |
| Apr. 29, 2004 |
Policies for storage of previously irradiated red cell units intended for transfusion to neonates ADDENDA May 4 & 5; Apr. 10 & 11, 2005 |
| Apr. 25, 2004 |
Problem in the use of two- versus four-cell screens in detection of certain antibodies when using the ABS 2000 system ADDENDA Apr. 29 |
| Apr. 19, 2004 |
Is there a need to irradiate cellular products for transfusion to potential organ donors and those used for perfusion of harvested organs? ADDENDA Apr. 20 |
| Apr. 19, 2004 |
In heart transplant patients receiving leukoreduced red cells is there evidence to support washing of the cells to remove soluble HLA antigens that might contribute to HLA alloimmunization and organ rejection? ADDENDA Apr. 23 & 25 |
| Apr. 12, 2004 |
Should preoperative autologous donation be discouraged or postponed in patients receiving agents that modify the immune system? |
| Apr. 8, 2004 |
Ensuring uniform policies for recipient antigen typing when there is variation in the stocking practices of typing antisera within a multiple hospital system |
| Apr. 8, 2004 |
Justification for requesting routine antibody identification and titer on women who have received RhIG during pregnancy ADDENDA Apr. 14 |
| Apr. 6, 2004 |
How prevalent is leukocyte reduction by filtration as a method of providing 'CMV-safe' components? ADDENDA Apr. 7, 8, 11 & 16 |
| Apr. 6, 2004 |
Issues arising from the discovery of unexpected antibodies in plateletpheresis products ADDENDA Apr. 7 & 8 |
| Apr. 6, 2004 |
Transfusion of Rh positive platelets to Rh negative neonates ADDENDA Apr. 8, May 18 & 19 |
| Apr. 3, 2004 |
Restrictions to the use of thawed plasma versus FFP ADDENDA Apr. 5, 6 & 8 |
| Apr. 1, 2004 |
Quality control of automated blood pressure cuffs used to evaluate blood donors ADDENDA Aug. 4, 2006 |
| Mar. 28, 2004 |
Validation of 'non-culture' methods to detect bacterial contamination of platelets |
| Mar. 27, 2004 |
Experience with Kiefel blood bags for pre-storage leukocyte-reduced red blood cells ADDENDA Mar. 30 |
| Mar. 27, 2004 |
Report of bubbles in the columns of ABD gel cards ADDENDA Mar. 30 |
| Mar. 25, 2004 |
Deferral policies for prospective donors who have undergone laparoscopic surgery ADDENDA Mar. 29 |
| Mar. 24, 2004 |
Refusal to use Rh positive platelets for an Rh negative male undergoing coronary artery bypass surgery ADDENDA Mar. 25 & Apr. 3 |
| Mar. 19, 2004 |
Managing discordant results for bacterial cultures between samples from plateletpheresis products at 24 hours and those from QA samples for sterility after 5-day storage ADDENDA Mar. 19 |
| Mar. 17, 2004 |
Provision of medical coverage for automated plasma collections |
| Mar. 15, 2004 |
Blood transfusions as a possible hidden source of lead exposure in neonates ADDENDA Mar. 15 |
| Mar. 11, 2004 |
Use of nucleic acid amplification testing (NAT) results in notification of blood donors to resolve uncertain results for HIV and HCV ADDENDA Mar. 11, 15, 16, 24 & 30 |
| Mar. 10, 2004 |
Notification of donors who test HIV and/or HCV ELISA positive but confirmatory testing is indeterminate or negative ADDENDA Mar. 12 |
| Mar. 9, 2004 |
Acceptable levels of hemolysis in samples submitted for donor infectious disease testing |
| Mar. 9, 2004 |
Goals and objectives for pathology residency training in donor room responsibilities ADDENDA Mar. 10 |
| Mar. 4, 2004 |
Maintaining inventories of plasma with low titer anti-T; ADDENDA Mar. 5; May 16, 2007 |
| Mar. 4, 2004 |
Managing new billing codes for CMV antibody negative blood products; ADDENDA Mar. 5 |
| Feb. 29, 2004 |
Experience and protocols using the MTS Gel System for 'special procedures' |
| Feb. 25, 2004 |
Involvement of alert and competent patients in verifying their own identification on blood component forms ADDENDA Feb. 26 |
| Feb. 23, 2004 |
Use of a 'blood patch' to treat severe headache due to cerebrospinal fluid leakage after epidural anesthesia ADDENDA Feb. 24, 25 & 26 |
| Feb. 18, 2004 |
Should directed donations intended for neonates be screened for CMV antibody in addition to being leukoreduced? ADDENDA Feb. 19 |
| Feb. 11, 2004 |
Should prospective blood donors be informed before donation of the possibility that one or more of their tests for infectious diseases may yield inconclusive results? |
| Feb. 8, 2004 |
Experience in using document control software to track SOPs ADDENDA Feb. 9 & 10; REACTIVATED Jan 16, 2005 |
| Feb. 8, 2004 |
Methods to obtain appropriate reaction strength when performing daily reagent QC using gel cards ADDENDA Feb. 10, 15 & 19 |
| Feb. 3, 2004 |
Administration of GCSF to granulocyte donors by hospitals on behalf of blood centers ADDENDA Feb. 5, 7, 9, 13, Mar. 21 & 24 |
| Jan. 29, 2004 |
Impact of new policies to eliminate tests for weak D on the decision to administer RhIG in pregnant women who were designated weak D on previous Rh testing protocols ADDENDA Jan. 30 & Feb. 5 |
| Jan. 28, 2004 |
Policies for dealing with the blood needs of massively bleeding patients with little chance of survival at a time of severe blood shortage ADDENDA Feb. 10 |
| Jan. 22, 2004 |
Protocols
for re-entry of blood donors who are HIV-1 EIA-reactive
but Western blot negative ADDENDA Jan.
23 & 30; July 11 & 27, Aug. 7, 2007 |
| Jan. 22, 2004 |
Should surgical repair of hip fracture be delayed in patients who are receiving the anti-platelet drug Plavix? ADDENDA Jan. 25; Sept. 19, 2005 |
| Jan. 20, 2004 |
Obtaining samples from platelet bags for pH/glucose testing by dipstick to detect bacterial contamination ADDENDA Jan. 21 & 26, Feb. 16 & 19 |
| Jan. 19, 2004 |
Complement-coated red cells for quality control of anti-C3d reactivity in an ID-MTS gel system for direct antiglobulin testing ADDENDA Jan. 20, 21 & 21 |
| Jan. 15, 2004 |
Should volunteer whole blood donors be allowed to donate more often than every 8 weeks during critical blood shortages? ADDENDA Jan. 15 & 21; May 7, 2008 |
| Jan. 13, 2004 |
Management of pre-admit surgery patients known to have previously identified antibodies ADDENDA Jan. 14 |
| Jan. 7, 2004 |
What do blood collection centers do with donors who are implicated in TRALI, and those whose blood is at high risk of causing TRALI? ADDENDA July 30, 2004; June 3, 2005; Nov. 15, 2006; Jan. 26 & 29; Feb. 5 & 26, 2007 |
Back to Top 
The e-Network Forum is supported in part by the California Blood Bank Society (CBBS) and the American Red Cross Blood Services (ARCBS) and endorses collegial discussion among blood banking and transfusion medicine professionals. However, neither the CBBS nor the ARCBS in any way endorse the specific views and opinions expressed in the forum. The forum is not intended as a substitute for medical or legal advice and the content should not be relied upon for any medical or legal purposes. Readers should make their own determinations as to: (i) what constitutes appropriate medical, technical, and administrative practices, and (ii) how best to comply with laws and regulations relevant to their questions. For the latter, they should consider consulting, as to any medical matters, a qualified physician, and, as to any legal matters, an attorney familiar with related state and federal laws. The user of the forum, by accessing same, assumes all risks arising out of such use and releases CBBS and their respective members, directors, officers and agents from and against any loss, damage, claim or liability arising out of such use of the Forum.
